Tolerability, Efficacy, and PK of ZSP1601 in Patients With Non-Alcoholic Steatohepatitis (NASH)

NCT04140123 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

37

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Alcoholic Steatohepatitis (NASH)

Interventions

DRUG: ZSP1601
DRUG: ZSP1601 Placebo

Sponsor

Guangdong Raynovent Biotech Co., Ltd